How to Get Enhertu (Fam-Trastuzumab Deruxtecan-nxki) Covered by Aetna in Michigan: Appeals Guide, Forms & Timelines
Quick Answer: If Aetna denied Enhertu (fam-trastuzumab deruxtecan-nxki), you have strong appeal rights in Michigan. Start with Aetna's internal appeal within 60 days, then file for Michigan DIFS external review within 127 days if denied. Key requirements: documented HER2 testing, prior therapy failures, and medical necessity letter citing